Hiroshi Furukawa

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

Mitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai et al. · Journal of Clinical Oncology · 2011 · 1.5K citations · Full text

Medicine, Oncology, Surgery +16

Recognition of a virus-encoded ligand by a natural killer cell activation receptor

Hamish R.C. Smith, Jonathan W. Heusel, Indira K. Mehta et al. · Proceedings of the National Academy of Sciences · 2002 · 754 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 502 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure–activity correlations with related alkaloids

Yoshiki Kashiwada, Akihiro Aoshima, Yasumasa Ikeshiro et al. · Bioorganic & Medicinal Chemistry · 2004 · 456 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

S Nakamori, Masao Kameyama, Susumu Imaoka et al. · PubMed · 1993 · 429 citations

Medicine, Oncology, Pathology +17